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Morphological MRI criteria improve
the detection of lymph node metastases
in head and neck squamous cell carcinoma:
multivariate logistic regression analysis of MRI
features of cervical lymph nodes
Abstract The aim was to evaluate
whether morphological criteria in ad-
dition to the size criterion results in
better diagnostic performance of MRI
for the detection of cervical lymph
node metastases in patients with head
and neck squamous cell carcinoma
(HNSCC). Two radiologists evaluated
44 consecutive patients in which
lymph node characteristics were
assessed with histopathological corre-
lation as gold standard. Assessed
criteria were the short axial diameter
and morphological criteria such as
border irregularity and homogeneity
of signal intensity on T2-weighted and
contrast-enhanced T1-weighted
images. Multivariate logistic regres-
sion analysis was performed: diag-
nostic odds ratios (DOR) with 95%
confidence intervals (95% CI) and
areas under the curve (AUCs) of
receiver-operating characteristic
(ROC) curves were determined.
Border irregularity and heterogeneity
of signal intensity on T2-weighted
images showed significantly increased
DORs. AUCs increased from 0.67
(95% CI: 0.61–0.73) using size only to
0.81 (95% CI: 0.75–0.87) using all
four criteria for observer 1 and from
0.68 (95% CI: 0.62–0.74) to 0.96
(95% CI: 0.94–0.98) for observer
2 (p<0.001). This study demonstrated
that the morphological criteria border
irregularity and heterogeneity of sig-
nal intensity on T2-weighted images
in addition to size significantly
improved the detection of cervical
lymph nodes metastases.
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Introduction
The presence of cervical lymph node metastases is an
important prognostic factor in patients with HNSCC as it
worsens significantly the treatment outcome [1–8]. The
choice of management depends on the existence and extent
of lymph node metastases in the neck. Therapy could
consist of surgery, radiation therapy, chemotherapy, or a
combined therapy. However, all these therapies have a
considerable morbidity and mortality. Therefore, treatment
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e-mail: R.beets.tan@mumc.nlrefinements like limitation of the field of radiation or a
more selective neck dissection are necessary [9–15]. MRI
is one of the imaging techniques that is used to guide
treatment decisions, but the ability of MRI to discriminate
between lymph nodes with and without metastasis is still
poor [16].
A commonly used criterion for the assessment of
cervical lymph node involvement on MRI is the short
axial diameter, and several studies have been undertaken to
determine the optimal cutoff size of the short axial diameter
for discrimination between metastatic and non-metastatic
lymph nodes. On MRI a commonly used sizecutoffpoint is
a short axial diameter of 10 mm, but a range varying from 9
to 15 mm has been described [17–21]. The challenge for
radiologists remains the detection of metastases in small
lymph nodes with a short axial diameter below 10 mm,
because mere use of the size criterion will result in
misclassification of these nodes as normal. In this respect,
according to the literature, the performance of MRI is still
poor for detection of lymph node metastases, and this
concerns especially the detection of metastases in small
lymph nodes [16].
In addition to the size criterion, the use of morphological
criteria might have added value to detect metastatic disease
in lymph nodes. The diagnostic value of morphological
criteria has not been well evaluated in patients with
HNSCC. In patients with rectal cancer, Kim et al.
demonstrated that in addition to the size criterion,
morphological criteria such as borders and heterogeneity
could be helpful signs to predict nodal involvement [22].
The aim of our study was to evaluate the accuracy and
additional diagnostic value of morphological criteria
observed on MRI images, such as border irregularity and
heterogeneity of the signal intensity on T2-weighted
images and heterogeneity of enhancement on post-contrast
T1-weighted images.
Materials and methods
Patients
This study was approved by the local medical ethics
committee. Between January 2002 and December 2006 a
series of 44 consecutive patients [mean age was 61 years
(range: 40–86 years); 11 women and 33 men] with a
HNSCC who underwent a unilateral or bilateral supra-
omohyoid neck dissection (SOHND) (dissection of levels
I-III) or radical (modified) neck dissection [R(M)ND]
(dissection of levels I-V) was studied. All patients
underwent MR imaging as part of the routine diagnostic
workup. This was performed on a 1.5-T machine
(Gyroscan, Powertrack 6000, Philips, Best, The Nether-
lands) by using a head-neck coil (Philips, Best, The
Netherlands). Table 1 presents the relevant parameters of
the MRI protocol.
MR evaluation
One general radiologist (observer 1) and one radiologist
specialized in head and neck imaging (observer 2)
independently evaluated the MR images retrospectively.
Both observers were blinded to each other’s MR assess-
ments, clinical information, and the results of the histo-
logical examination.
Table 1 Parameters of the head and neck MRI protocol
Parameters Sequences
TSE T1-weighted SPIR
a TSE T2-weighted SPIR CE
b T1-weighted SPIR CE T1-weighted
Field of view (mm) 220 220 220 220
Slice orientation Transverse Transverse Coronal Transverse
Matrix 512 512 512 513
Section thickness (mm) 3 3 3 3
No. of sections 65 65 50 65
No. of signals acquired 3 3 3 3
Acquisition time (min:s) 5:37 5:09 6:05 6:40
TSE
c factor 3 20 4 4
TE
d(ms) 13 80 14.50 14.50
TR
e (ms) 530 Shortest 500 500
Slice gap 0 0 0 0
aSPIR spectral pre saturation inversion recovery
bCE contrast enhanced
cTSE turbo spin echo
dTE echo time
eTR repitition time
627In the first session, all lymph nodes were determined by
position and slice number per neck level. The short axial
diameter was recorded per lymph node. All lymph nodes
were classified as normal (≤10 mm) or malignant
(>10 mm).
After a time interval of 8 weeks, the same MR images
were reviewed again by the same radiologists blinded to
each others’ MR assessments, clinical information, and the
results of the histological examination. For every lymph
node the decision was made whether it was normal or
metastatic using three morphologic criteria. The first
criterion was border as observed on fat-suppressed T2-
weighted images (smooth, lobulated, spiculated, indistinct)
(Fig. 1 demonstrates the four different borders on the
Fig. 1 Schematic drawing of
the four borders for assessment
of lymph nodes
Fig. 2 Transverse turbo spin-
echo T2-weighted images of the
neck. Examples of the four
different scores on border
regularity. The lymph nodes
(arrows) show (A) a smooth
border, (B) a lobulated border,
(C) a spiculated border, and (D)
an indistinct border
628schematic drawing). Smooth (Fig. 2A) and lobulated
(Fig. 2B) borders were considered as indicative of normal
lymph nodes. Spiculated (Fig. 2C) and indistinct (Fig. 2D)
borders were considered as indicative of metastatic lymph
nodes. The second criterion was degree of homogeneity of
the signal intensity on contrast-enhanced T1-weighted
images. A homogeneous enhancement was considered as
normal. A heterogeneous enhancement was considered as
indicativeofmetastaticlymphnodes.Thethirdcriterionwas
degree of homogeneity of the signal intensity on T2-
weighted images. A homogeneous signal intensity was
considered as normal. A heterogeneous signal intensity was
considered as indicative of metastatic lymph nodes (Fig. 3).
Pathological examination
All neck dissections were performed en bloc. Immediately
after the resection, the surgeon positioned the neck
dissection specimen on a schematic drawing of the neck
in real proportions and fixed it with needles (Fig. 4). The
pathologist manually identified and localized the lymph
nodes per neck level in the specimen. The short axial
diameter of all lymph nodes was recorded. Subsequently,
lymph nodes were fixed, sectioned, and hematoxyline-
eosine (HE) stained, and the presence of tumor in each
lymph node was examined microscopically. The patholog-
ical results were used as the reference standard.
Matching MR assessment to pathological examination
The neck was subdivided according to the six different
levels in agreement with the classification of the American
Joint Committee on Cancer (AJCC); this classification was
used by the radiologists when viewing the MR images and
used by the pathologist when interpreting the specimen
after neck dissection [23].
The results of the measurements on MRI were compared
with the results of the pathologic examination of the neck
dissection specimens. By recording the combination of the
short axial diameter and the exact location of each lymph
node, it was possible to perform a topographical correlation
for each lymph node per neck level.
Statistical analysis
Inter-observer agreement with respect to the evaluation of
the criterion nodal size, and the criteria border irregular-
ity, homogeneity of contrast enhancement on T1-
weighted images, and homogeneity of signal intensity
on T2-weighted images was expressed by Cohen’s kappa
coefficient (κ).
For each lymph node, the scores for the MRI criteria
were correlated with the outcome of the histological
Fig. 3 Transverse turbo spin-echo T2-weighted image of the neck
showing an example of heterogeneous signal intensity (SI) in a
lymph node in level II on the right side. The lymph node
(arrowhead) with a homogenous SI, although a short axial diameter
of 13 mm, showed no metastasis, whereas the smaller lymph node
(arrow) (short axial diameter 9 mm) with a heterogeneous and
eccentric area of low SI (small arrow) revealed metastasis at the
pathologic examination
Fig. 4 Schematic drawing of the different levels in the neck
629examination of the neck dissection specimen: presence or
absence of lymph node metastasis. Diagnostic perfor-
mances of nodal size and the new criteria for the diagnosis
of metastasis were evaluated using diagnostic parameters,
such as sensitivity, specificity, and diagnostic odds ratio
(DOR). In diagnosis, one always has to compromise
between sensitivity and specificity: as sensitivity increases,
specificity will decrease and vice versa. The DOR is a
measure of diagnostic performance, which incorporates
sensitivity and specificity and thus captures the trade-off
between these measures. A DOR=1 indicates that the test
under study has no diagnostic value; a DOR>1 indicates
that the test under study (in this case, the new MRI criteria)
has the ability to discriminate between lymph nodes with
and without metastasis. The larger the DOR is, the larger
the discriminative ability [24].
Multivariate logistic regression analysis was used to
evaluate whether a criterion, when used in combination
with the other criteria, can be used as an independent
indicator for differentiating metastatic from non-metastatic
lymph nodes. The independent contribution of each
criterion to the diagnostic performance is expressed as
the DOR, which can be derived by exponentiation of the
corresponding regression coefficient, where 95% con-
fidence intervals (95% CI) are used to indicate whether
the DOR is significantly different from DOR=1. Multi-
variate logistic regression analysis was also used to
examine which of the new MRI criteria were most
predictive of the presence of metastases and whether the
use of these new criteria in addition to size significantly
improved the detection of cervical lymph nodes metas-
tases in HNSCC.
The dependent variable in these models was the presence
or absence of metastasis according to the pathological
examination. The models incorporated as independent
variable size as well as the three new MRI criteria. All
criteria were entered as dichotomous variables, where
abnormal and normal results were coded as 1 and 0,
respectively.
Predicted probabilities of metastasis from these models
were used to calculate the area under the curve (AUC) with
95% CI as measure of diagnostic performance. The AUC
of the model incorporating both the new criteria and the
size criterion was compared with the AUC of the model
that incorporated only the size criterion. The difference in
AUCs for the different models was tested using the method
described by Hanley et al., which accounts for the fact that
the AUCs are derived from the same sample of patients
[25]. A p-value <0.05 was considered to be statistically
significant.
Results
In 44 patients a neck dissection was performed: 9
supraomohyoid neck dissections and 37 radical (modi-
fied) neck dissections (in 2 patients a bilateral neck
dissections). Distribution of the dissected neck levels was
as follows; 32 level I, 41 level II, 34 level III, 25 level
IV, and 8 level V.
At pathological examination a total of 261 lymph nodes
was found: 71 lymph nodes with metastasis and 190
without metastasis (prevalence=27.2%). In all levels
together, a total of 111 lymph nodes was found in level
II, 52 lymph nodes in level I, 65 lymph nodes in level III,
25 lymph nodes in level IV, and 8 lymph nodes in level V.
Lymph node metastases were present in 33 patients (patient
prevalence=80.5%). The majority (82%) of 261 assessed
lymph nodes was scored as having a size <10 mm. The
average pathologic yield per patient was 11.5 lymph nodes.
At assessment of the MR images of the dissected neck
levels,atotalof360lymphnodeswasdetected.Oftheselymph
nodes,99wereshowntohaveashortaxialdiameterof≤3mm.
Because these lymph nodes were not detected at pathological
examination, they were excluded from further analysis.
A total of 261 lymph nodes, which was found at
pathological examination, was matched to lymph nodes
that were detected on MRI by the two observers.
For observer 1, scores were lacking in 1 lymph node
metastasis, leaving 260 lymph nodes for analysis: 70 lymph
nodeswithmetastasisand190withoutmetastasis.Forobserver
2, complete data were available for all 261 lymph nodes.
Observer agreement was κ=1.00 for size, κ=0.62 for
border irregularity, κ=0.51 for signal intensity on contrast-
enhanced T1-weighted images, and κ=0.51 for signal
intensity on T2-weighted images.
Table 2 shows the sensitivity, specificity, and diagnostic
odds ratio (DOR) with 95% confidence interval (95% CI) for
the diagnosis of metastasis for the criteria border (abnormal
versus normal) on T2-weighted images, signal intensity on
contrast-enhanced T1-weighted images (heterogeneous ver-
sus homogeneous), and signal intensity on T2-weighted
images (heterogeneous versus homogeneous) for the two
observers. With respect to the new criteria, the highest DORs
are found for border irregularity and signal intensity on T2-
weighted images. The lowest DORs are found for the
criterion contrast enhancement on T1-weighted images.
Table 3 shows the results for lymph nodes that were
smaller than 10 mm. The DORs associated with the new
criteria are smaller compared to the DORs for all lymph
nodes, but are still elevated, indicating that the morpho-
logic criteria are also useful for the detection of metastases
in small lymph nodes.
Table 4 shows the results from multivariate logistic
regression analyses. The DORs associated with border
irregularity were 2.61 (95% CI: 1.12–6.08) and 66.2 (95%
CI: 20.4 -217) for observer 1 and 2, respectively; for
heterogeneity on T2-weighted images DORs were 2.97
(95% CI: 1.42–6.18) and 22.6 (95% CI: 6.40–80.1). The
DORs associated with heterogeneity on T1-weighted
images are not significantly different from DOR=1.
Another observation was that for observer 2, the DOR
630associated with size was 1.02, indicating that for this
observer size had no additional diagnostic value when
considered in combination with the other criteria.
TheAUCs forpredictivemodelsusingsizeonly(≤10 mm
versus >10 mm) were 0.67 (95% CI: 0.61–0.73) and 0.68
(95%CI:0.62–0.74)forobserver1and2,respectively.After
incorporationofthethreenewcriteriaintomodels,theAUCs
increased significantly to 0.81 (95% CI: 0.75–0.87) for
observer1andto0.96(95%CI:0.94–0.98)forobserver2(p
<0.001). When the criterion “homogeneity of the signal
intensity on contrast-enhanced T1-weighted images” was
omitted from the predictive model, there was only a very
smalldecreaseinAUCforobserver1from0.81to0.79(95%
CI: 0.73–0.85) and remained 0.96 (95% CI: 0.93–0.98) for
observer 2. This observation indicates that this criterion has
little added diagnostic value.
Discussion
The principal finding of this study was that in addition to
the size criterion, new criteria, such as border irregularity
and heterogeneity on T2-weighted images, result in a better
diagnostic performance of MRI for the detection of cervical
lymph node metastases in HNSCC.
Accurate assessment of cervical lymph node metastases
in HNSCC is important regarding prognosis and choice of
management. Detection of lymph node metastases is
usually based on the short axial diameter as size criterion.
However, many studies have shown that the size criterion
alone was not accurate enough as predictor for lymph node
metastasis [16]. Sensitivity is poor when the commonly
chosen cutoffvalue of 10 mm is used, and although use of a
lower cutoff value, as proposed by van den Brekel et al.,
results in higher sensitivity, lower cutoff values are
associated with low specificity [26]. We evaluated in this
study the effect on sensitivity and specificity when
lowering the cutoff point from 10 to 7 mm in short axial
diameter; sensitivity raised from 43% to 79%, but the
associated specificity expectedly lowered from 92% to
64%. However, the corresponding diagnostic odds ratios
(DORs) did not differ significantly (DOR=8.16 with 95%
CI 4.09–16.3 versus DOR=6.43 with 95% CI 3.38–12.23).
Another assessment of lymph node dimensions is the
measurement of ratios of maximum longitudinal to maxi-
mum short axial diameter (l/s ratio). A ratio less than 2, like
in round lymph nodes versus elliptical lymph nodes, is
indicative of metastatic disease, but this is related to
enlarged lymph nodes. Because in our presented series
82% of all assessed lymph nodes were not enlarged –
showing short axial diameters less than 10mm – weused in
this study the 10-mm short axial diameter as cutoff point.
Additional morphological criteria for the detection of
lymph node metastasis have been evaluated in this study:
Table 3 Sensitivity, specificity, and diagnostic odds ratio (DOR) with 95% confidence interval (95% CI) for the diagnosis of metastasis for
the MR criteria: size, border irregularity, signal intensity (SI) on contrast-enhanced (CE) T1-weighted images and SI on T2-weighted images
for lymph nodes <10 mm in short axial diameter
Observer 1 Observer 2
Lymph nodes <10 mm Sensitivity Specificity DOR (95% CI) Sensitivity Specificity DOR (95% CI)
Borders on T2-weighted images spiculated/
indistinct versus smooth/lobulated
40 87 4.61 (2.12–9.99) 78 97 99.6 (33.1–299)
SI on CE T1-weighted images heterogeneous
versus homogeneous
53 70 2.52 (1.25–5.08) 42 68 1.49 (0.74–3.00)
SI on T2-weighted images heterogeneous
versus homogeneous
53 79 4.24 (2.06–8.71) 88 68 15.6 (5.70–41.8)
Table 2 Sensitivity, specificity, and diagnostic odds ratio (DOR) with 95% confidence interval (95% CI) for the diagnosis of metastasis for
the MR criteria: size, border irregularity, signal intensity (SI) on contrast-enhanced (CE) T1-weighted images and SI on T2-weighted images
for all lymph nodes
Observer 1 Observer 2
All lymph nodes Sensitivity Specificity DOR (95% CI) Sensitivity Specificity DOR (95% CI)
Short axial diameter (mm) >10 versus ≤10 43 92 8.16 (4.09–16.3) 42 92 7.96 (3.99–15.9)
Borders on T2-weighted images spiculated/
indistinct versus smooth/lobulated
63 84 8.68 (4.69–16.1) 87 94 112 (44.7–280)
SI on CE T1-weighted images heterogeneous
versus homogeneous
71 66 4.81 (2.65–8.71) 61 65 2.89 (1.65–5.05)
SI on T2-weighted images heterogeneous
versus homogeneous
67 77 6.99 (3.83–12.7) 93 68 28.6 (11.3–72.3)
631the degree of border irregularity on T2-weighted images,
homogeneity of the signal intensity on contrast-enhanced
T1-weighted images, and the homogeneity of the signal
intensity on T2-weighted images of lymph nodes.
The results of univariate analyses, with which we
compared the diagnostic performance of all four criteria
understudy,indicatethatallcriteria,whenusedalone,helpto
discriminate between lymph nodes with and without metas-
tasis,butthatthediscriminativeabilitywaslowestfordegree
of homogeneity of signal intensity on contrast-enhanced T1-
weighted images. This finding also holds after restricting the
analysis to lymph nodes smaller than 10 mm. However,
whencomparedwiththeanalysisinvolvingalllymphnodes,
DORs were lower, indicating that within small nodes the
discriminative ability is poorer. An exception was border
irregularity, which for observer 2 was still associated with a
highDOR of about 100(comparedwitha DOR of112inthe
analysis based on all lymph nodes).
Another morphological criterion that has been used is the
presence of central necrosis. However, central necrosis is
often seen in the larger involved lymph nodes, which based
on their size only would have been classified as malignant
anyhow [17–20]. The majority of lymph nodes in our series
(82%) showed subcentrimetrical short axial diameters.
Curtin et al. have already described the diagnostic value
of the appearance of internal abnormalities in lymph nodes
on CTand MRI; however, the performance of MRI was not
changed significantly by the addition of information on
internal abnormalities [18].
Evaluationoftheresultsofmultivariatelogisticregression
analysis indicates that, if used in combination with the size
criterion, for both observers the scores on border irregularity
and heterogeneous signal intensity on T2-weighted images
contribute significantly to the prediction of the presence of
metastatic lymph nodes, whereas the criterion heterogeneity
ofsignalintensityoncontrast-enhancedT1-weightedimages
has no additional diagnostic value.
Explanations for the MR features in metastatic lymph
nodes could be the following. Firstly, changes of a smooth
or lobulated border of normal lymph nodes into a
spiculated or indistinct border could be due to direct
extra-nodal tumor infiltration into the peri-nodal fatty
tissue. Secondly, this phenomenon could be explained by a
desmoplastic reaction around the affected lymph node, the
similar feature that can be observed around a primary
tumor site. Thirdly, tumor infiltration and presence of
softening or necrosis within lymph nodes usually show on
the pathological examination an irregular and heterogene-
ous pattern. This architectural distortion of the nodal
parenchyma results in an irregular signal intensity on T2-
weighted images and in a heterogeneous signal intensity on
the contrast-enhanced T1-weighted images.
The discrepancies in diagnostic performance between
the two observers and low inter-observer agreement
regarding the new morphological criteria could be
explained by the fact that observer 2, experienced in
head and neck radiology, was better aware of the
diagnostic value of border irregularity and homogeneity
of signal intensity than his colleague who had less
experience in the assessment of lymph node involve-
ment. In this respect, the results also show that the
criterion size for lymph nodes has limited discriminative
value for the experienced observer 2. For the more
experienced observer, border irregularity and heteroge-
neity of signal intensity on T2-weighted images are
more decisive in the diagnosis. This is reflected by the
results of the univariate analysis with high DORs for the
criteria border and signal intensity on T2-weighted
images (112 and 28.6, respectively), when compared
with the low DOR for the size criterion (7.96). Also, in
the multivariate logistic regression analysis high DORs
are presented for those criteria (66.2 and 22.6,
respectively). This is in contrast to the DOR of 1.02
for the size criterion.
Conclusion
Newly assessed morphological criteria like border irregular-
ity and heterogeneity of signal intensity on T2-weighted
images in addition to size significantly improved the
detection of cervical lymph node metastases on MRI in
patients with HNSCC.
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Creative Commons Attribution Noncommercial License which
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Table 4 Results of multivariate logistic regression analyses. Regression coefficients (β), diagnostic odds ratios (DOR) with 95%
confidence intervals (95% CI) for the size criterion, and the three new assessed MR criteria border, signal intensity (SI) on contrast-enhanced
(CE) T1-weighted images and T2-weighted images for both MR observers
Observer 1 Observer 2
MRI criteria β DOR (95% CI) β DOR (95% CI)
Size >10 versus ≤10 mm 1.06 2.89 (1.25–6.70) 0.02 1.02 (0.25–4.18)
Border on T2-weighted images spiculated/indistinct versus smooth/lobulated 0.96 2.61 (1.12–6.08) 4.20 66.2 (20.4–217)
SI on CE T1-weighted images heterogeneous versus homogeneous 0.37 1.45 (0.67–3.14) 0.68 1.97 (0.70–5.59)
SI on T2-weighted images heterogeneous versus homogeneous 1.09 2.97 (1.42–6.18) 3.12 22.6 (6.40–80.1)
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